Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis
article
OA: closed
CC0
⤵ 18 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the effects of danazol on plasma lipid and lipoprotein levels in healthy women and women with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Cholesterol, High Density Lipoprotein and Danazol via openalex
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- DANAZOL AND CHOLESTEROL METABOLISM via openalex
- Danazol: Endocrine consequences in healthy women via openalex
- Effect of danazol on plasma lipid and lipoprotein levels in normal women via openalex
- Effects of danazol and lynestrenol on serum lipoproteins in endometriosis via openalex
- Metabolic effects of danazol. via openalex
- W2031731441 via openalex
- W1991773279 via openalex
- W2051890370 via openalex
- W2073018115 via openalex
- W2081242789 via openalex
- W1713198226 via openalex
- W2090348568 via openalex
- W2094768566 via openalex
- W1652237749 via openalex
- W1542558639 via openalex
- W2210149071 via openalex
- W2332627412 via openalex
- W2408489548 via openalex
- W2415945971 via openalex
- W2462539497 via openalex
- W4285719527 via openalex
- W2010657017 via openalex
- W6793613985 via openalex
Cited by (18)
- Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis 2022
- Medical management of endometriosis 2021
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile 2007
- Danazol treatment of endometriosis-associated pain 2006
- Endometriosis<b>Laparoscopy—Diagnostic and Therapeutic Approaches</b> 1997
- Changing concepts of medical treatment of endometriosis 1993
- Endometriosis—the role of medroxyprogesterone acetate 1992
- Medical treatment of mild endometriosis associated with infertility 1991
- 5 Heterosteroids and Drug Research 1991
- Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol 1989
- Danazol therapy renders red cells resistant to osmotic lysis <sup>1</sup> 1989
- Hormonal Therapy of Endometriosis 1989
- Lipid Metabolism During Treatment of Endometriosis with the Progestin Dienogest 1989
- A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis 1988
- Cyclical mastopathy: A critical review of therapy 1988
- Gynecologic Problems of Adolescence 1985
- Plasma lipoproteins during and after danazol treatment 1984
- Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women 1984
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:55.985569+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK